Johnson & Johnson Earnings Preview: What to Expect

With a market cap of $580.1 billion, Johnson & Johnson (JNJ) is a global healthcare company engaged in the research, development, manufacture, and sale of a broad range of medical products and solutions through its Innovative Medicine and MedTech segments. It serves healthcare providers, hospitals, retailers, and patients worldwide across areas including pharmaceuticals, surgery, orthopedics, cardiovascular care, and vision health.

The New Brunswick, New Jersey-based company is expected to unveil its fiscal Q2 2026 results before the market opens on Wednesday, Jul. 15. Ahead of the event, analysts forecast JNJ to post an adjusted EPS of $2.83, a growth of 2.2% from $2.77 in the same quarter last year. It has surpassed Wall Street's bottom-line projections in the past four quarters.

Palantir Stock Crashes to a 52-Week Low: Why It's Time to Buy the Dip.

Corning Stock Skyrockets on AI-Related Demand, Spurring Unusual Call Option Buying

AMD's MEXT Acquisition Is More Important Than Markets Realize. Here's How It Solves the Memory Bottleneck.

Stop Missing Market Moves: Get the FREE Barchart Brief – your midday dose of stock movers, trending sectors, and actionable trade ideas, deli

Fuente original: Yahoo Finance (https://finance.yahoo.com/healthcare/articles/johnson-johnson-earnings-preview-expect-143210423.html)